Skip to main content
WUXIF logo

WuXi AppTec Co., Ltd. (WUXIF) Stock Price & Analysis

WuXi AppTec Co., Ltd. (WUXIF) — price $25.06 (0.00%), as of the Nov 19, 2026 trading session; market cap $76.1B.

Educational signal · not a buy or sell recommendation · How to read this

$25.06 $0.00 (0.00%) Market Cap $76.1B

WuXi AppTec Co., Ltd. · WUXIF · Healthcare · Diagnostics & Research

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States,…

Price as of Nov 19, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$25.06
Change on the day0.00%
52-week range$13.60–$29.10
Market capitalisation$76.1B—
Price / earnings (trailing)15.46
Shares traded on the day100
Beta (volatility vs the S&P 500)0.61

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 19, 2026: low $14, high $28, latest $25. $28 $14 high $28 Oct 17, 2025 Nov 19, 2026 · $25 $15Oct 17, 2025$15Oct 31, 2025$15Nov 14, 2025$14Nov 28, 2025$14Dec 12, 2025$14Dec 26, 2025$14Jan 9, 2026$15Jan 23, 2026$14Feb 6, 2026$14Feb 20, 2026$14Mar 6, 2026$14Mar 20, 2026$14Apr 2, 2026$14Apr 17, 2026$14May 1, 2026$14May 15, 2026$18May 29, 2026$16Jun 12, 2026$16Jun 26, 2026$21Jul 10, 2026$23Jul 24, 2026$21Aug 7, 2026$28Aug 21, 2026$26Sep 4, 2026$26Sep 18, 2026$27Oct 2, 2026$27Oct 16, 2026$23Oct 30, 2026$25Nov 13, 2026

Point at or tab to any week for its close.

Other perspectives

Council score for WuXi AppTec Co. (WUXIF): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

3 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Neutral read
Moon AI lens (model) Favorable read

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Strong
Margin of Safety Fairly Valued
Profit Margin Strong
Revenue Growth Moderate
Debt/Equity Moderate
ROE Strong
Gross Margin Moderate

Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is WuXi AppTec Co. (WUXIF), and what does it report?

Short answer

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States,… WuXi AppTec Co., Ltd. (WUXIF) is classified as Healthcare / Diagnostics & Research. Headquarters: 288 Fute Zhong Road, Shanghai, 200131, China. It employs 33,834 people. In Q2 FY2026 it reported revenue of CN¥16.39B and net income of CN¥6.38B. The market values it at $76.1B.

2 · Latest results

What do the latest results show for WuXi AppTec Co. (WUXIF)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of CN¥16.39B. Against analyst estimates the company has EPS beat 5 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026CN¥16.39BCN¥6.38BCN¥2.17 (diluted)
Q1 FY2026CN¥12.44BCN¥4.65BCN¥1.58 (diluted)
Q4 FY2025CN¥12.60BCN¥7.08BCN¥2.44 (diluted)
Q3 FY2025CN¥12.04BCN¥3.51BCN¥1.21 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for WuXi AppTec Co. (WUXIF)?

Short answer · as of

The distress and quality screens read Altman Z 12.33 · Piotroski F 5. Trailing ratios: ROE 30.0% · ROA 14.3% · current ratio 3.43.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held WUXIF in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported WUXIF in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about WuXi AppTec Co. (WUXIF)?

Read these with our analysis →

What Investors Ask About WuXi AppTec Co. (WUXIF) — Healthcare

These answers are editorial: 1 of these 8 answers is drawn from the WUXIF research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is WUXIF a good stock to buy?

Stock Expert AI does not rate WUXIF buy, sell or hold. WuXi AppTec Co., Ltd. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the WUXIF stock price today?

The last price recorded for WuXi AppTec Co., Ltd. (WUXIF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

How does WuXi AppTec Co., Ltd. contribute to drug development?

WuXi AppTec Co., Ltd. plays a pivotal role in global drug development by offering comprehensive contract research, development, and manufacturing (CRDMO) services.

What are the key factors to evaluate for WUXIF?

Evaluate WUXIF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Expanding CRDMO Services: The global demand for outsourced R&D and manufacturing services continues to grow, driven by pharmaceutical companies seeking to enhance efficiency and access specialized capabilities. Not financial advice.

How frequently does WUXIF data refresh on this page?

WUXIF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven WUXIF's recent stock price performance?

WuXi AppTec Co., Ltd. (WUXIF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive CRDMO capabilities covering the entire drug development lifecycle. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider WUXIF overvalued or undervalued right now?

The trailing P/E of WuXi AppTec Co., Ltd. (WUXIF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research WUXIF before investing?

Before investing in WuXi AppTec Co., Ltd. (WUXIF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 18 figures on this page — 15 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.